News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Paradigm Shift in the Management of Clostridium Difficile Infections

EP. 1: Clostridioides Difficile Pathogenesis & Manifestation

ByContagion
November 18th 2020

EP. 2: Managing Recurrent Clostridium Difficile Infections

ByContagion
November 18th 2020

EP. 3: RBX2660 for Recurrent Clostridioides Difficile

ByContagion
November 18th 2020

EP. 4: Antibiotic Microbial Resistance & RBX7455 for C Diff

ByContagion
November 18th 2020

EP. 5: Clostridioides Difficile: Exciting Developments

ByContagion
November 18th 2020

EP. 6: Frequency of CDI Recurrence and Impact on Quality of Life

ByContagion
November 18th 2020

EP. 7: Risk Factors for Recurrence of Clostridioides Difficile

ByContagion
November 18th 2020

EP. 8: Treatment Recommendations from IDSA/SHEA for CDI

ByContagion
November 18th 2020

EP. 9: Expanded Role of Fidaxomicin in Treatment of CDI

ByContagion
November 18th 2020

EP. 10: IDSA/SHEA Guidelines Update and ID Week: Bezlotoxumab

ByContagion
November 18th 2020

EP. 11: Fecal Microbiota Transplant for Recurrent vs Refractory CDI

ByContagion
November 18th 2020

EP. 12: Fecal Microbiota Transplant Outcomes and Therapy Advances

ByContagion
November 18th 2020
Advertisement
Advertisement

Trending on Contagion Live

1

Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint

2

Meet SIDP’s President Elect: Lisa Dumkow, PharmD, FIDP, BCIDP

3

Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix

4

Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections

5

Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us